Searched for
ASTRAZENECA NEWS
'No discussions' over AstraZeneca-Bristol Myers deal, senior source saysAstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no deal was eve...- US stocks: US market starts the month strong as Mideast deal hopes riseMajor US stock indexes opened higher on Monday. De-escalating Middle East tensions helped drag down crude oil prices. Investors are now pre...
- Global Market: European shares rise as easing Iran tensions lift sentiment; energy stocks slideAccording to Reuters, investor sentiment improved after Trump signalled a preference for diplomacy over immediate military action against I...
- A $100 question and all you need to know about markets for next weekGlobal markets face a pivotal week as the Federal Reserve, Bank of Japan and Bank of England meet against the backdrop of the Middle East c...
- AstraZeneca 'magic' faces rare test after trial failure, share slideAstraZeneca's nerve drug Wainua unexpectedly failed a late-stage heart disease trial. This setback has caused investor concern and impacted...
- Samsung Electronics denies report that it is exploring US listingSamsung Electronics denied exploring a U.S. listing of American Depositary Receipts. Bloomberg News had reported preliminary discussions wi...
- China detains AstraZeneca staff in data, drug-import probes: Report"We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," ...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- AstraZeneca to seek US approval of COVID vaccine in 2nd halfThe Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its s...
- Norway should exclude J&J, AstraZeneca from COVID vaccine scheme, says commissionOn April 15, the Norwegian Institute of Public Health said the AstraZeneca vaccine should be dropped entirely but the government sought fur...
- EU sues AstraZeneca over delayed deliveries of COVID-19 vaccine"AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. ...
- AstraZeneca has not reacted yet to EU letter on vaccines - Italian daily CorriereThe European Union member states and the pharmaceutical company are at odds over the delivery of the shots after the group shipped to the b...
- France to recommend mRNA COVID-19 shots as second dose for some after AstraZeneca: MinisterConfidence in the AstraZeneca vaccine has dropped in Europe since a very few, mostly young, recipients of the shot were found to have suffe...
- German cities suspend AstraZeneca vaccine use for under-60sThe decision came after the country's medical regulator announced that it had received a total of 31 reports of rare blood clots in recent ...
- AstraZeneca Covid shots not recommended for under 55s in CanadaManitoba and Quebec provinces were the first to heed the new National Advisory Committee on Immunization and Health (NACI) guidelines, with...
- UK PM Boris Johnson says he will get Oxford/AstraZeneca COVID-19 vaccine very soonBritish Prime Minister Boris Johnson said on Wednesday he would get the Oxford/AstraZeneca COVID-19 shot very soon, voicing his confidence ...
- Canada sure all that COVID-19 vaccines are safe, including AstraZeneca doses: PMCanadian health experts are sure all COVID-19 vaccines being administered in the country are safe, including those made by AstraZeneca PLC,...
- 2020's parting shot: India to roll out COVID-19 vaccine in January"India is a part of 'COVAX'. We will keep giving 50 per cent of everything we make to India and to COVAX at the same time. India has such a...
- Dr Reddy's trades steady, shrugs off legal challengeDRL’s generic version was to be marketed as Ticaflo, according to those in the know.
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
Load More
